Added to YB: 2026-08-19
Pitch date: 2026-08-16
HIMS [neutral]
Hims & Hers Health, Inc.
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$6.6B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
806.05
P/E
-45.27
EV/Sales
2.82
Sector
Health Care Providers and Services
Category
growth
Hims Q2-2026 Earnings Digest
HIMS (earnings): Q2-FY26 rated 6/10. ARPU +38%, ~3M subs, but growth driven by Eucalyptus M&A (intl +17x YoY), US only +16% organic. Added Wegovy/Zepbound via Lilly/Novo. Margins hit as biz shifts to lower-margin 3rd-party GLP-1; G&A tripled. Current ratio <1, refinancing risk. Guides 50%+ H2 growth, FY30 rev raised to $6.5B. Support at $25.
Read full article (4 min)